Literature DB >> 20382980

H3K27 trimethylation is an early epigenetic event of p16INK4a silencing for regaining tumorigenesis in fusion reprogrammed hepatoma cells.

Jia-Yi Yao1, Lei Zhang, Xin Zhang, Zhi-Ying He, Yue Ma, Li-Jian Hui, Xin Wang, Yi-Ping Hu.   

Abstract

Stable epigenetic silencing of p16(INK4a) is a common event in hepatocellular carcinoma (HCC) cells, which is associated with abnormal cell proliferation and liberation from cell cycle arrest. Understanding the early epigenetic events in silencing p16(INK4a) expression may illuminate a prognostic strategy to block HCC development. Toward this end, we created a reprogram cell model by the fusion mouse HCC cells with mouse embryonic stem cells, in which the ES-Hepa hybrids forfeited HCC cell characteristics along with reactivation of the silenced p16(INK4a). HCC characteristics, in terms of gene expression pattern and tumorigenic potential, was restored upon induced differentiation of these reprogrammed ES-Hepa hybrids. The histone methylation pattern relative to p16(INK4a) silencing during differentiation of the ES-Hepa hybrids was analyzed. H3K27 trimethylation at the p16(INK4a) promoter region, occurring in the early onset of p16(INK4a) silencing, was followed by H3K9 dimethylation at later stages. During the induced differentiation of the ES-Hepa hybrids, H3K4 di- and trimethylations were maintained at high levels during the silencing of p16(INK4a), strongly suggesting that H3K4 methylation events did not cause the silencing of p16(INK4a). Our results suggested that the enrichment of H3K27 trimethylation, independent of H3K9 dimethylation, trimethylation, and DNA methylation, was an early event in the silencing of p16(INK4a) during the tumor development. This unique chromatin pattern may be a heritable marker of epigenetic regulation for p16(INK4a) silencing during the developmental process of hepatocellular carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20382980      PMCID: PMC2881805          DOI: 10.1074/jbc.M109.077974

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Erasure of cellular memory by fusion with pluripotent cells.

Authors:  Jeong Tae Do; Dong Wook Han; Luca Gentile; Ingeborg Sobek-Klocke; Martin Stehling; Hoon Taek Lee; Hans R Schöler
Journal:  Stem Cells       Date:  2007-01-11       Impact factor: 6.277

2.  Targeted chromosome elimination from ES-somatic hybrid cells.

Authors:  Hiroyuki Matsumura; Masako Tada; Tomomi Otsuji; Kentaro Yasuchika; Norio Nakatsuji; Azim Surani; Takashi Tada
Journal:  Nat Methods       Date:  2006-11-05       Impact factor: 28.547

Review 3.  Reprogramming somatic gene activity by fusion with pluripotent cells.

Authors:  Jeong Tae Do; Dong Wook Han; Hans R Schöler
Journal:  Stem Cell Rev       Date:  2006       Impact factor: 5.739

4.  A stem cell-like chromatin pattern may predispose tumor suppressor genes to DNA hypermethylation and heritable silencing.

Authors:  Joyce E Ohm; Kelly M McGarvey; Xiaobing Yu; Linzhao Cheng; Kornel E Schuebel; Leslie Cope; Helai P Mohammad; Wei Chen; Vincent C Daniel; Wayne Yu; David M Berman; Thomas Jenuwein; Kevin Pruitt; Saul J Sharkis; D Neil Watkins; James G Herman; Stephen B Baylin
Journal:  Nat Genet       Date:  2007-01-09       Impact factor: 38.330

5.  In situ detection of the hypermethylation-induced inactivation of the p16 gene as an early event in oncogenesis.

Authors:  G J Nuovo; T W Plaia; S A Belinsky; S B Baylin; J G Herman
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 6.  The regulation of INK4/ARF in cancer and aging.

Authors:  William Y Kim; Norman E Sharpless
Journal:  Cell       Date:  2006-10-20       Impact factor: 41.582

7.  Normal human mammary epithelial cells spontaneously escape senescence and acquire genomic changes.

Authors:  S R Romanov; B K Kozakiewicz; C R Holst; M R Stampfer; L M Haupt; T D Tlsty
Journal:  Nature       Date:  2001-02-01       Impact factor: 49.962

Review 8.  Reprogramming metastatic tumour cells with embryonic microenvironments.

Authors:  Mary J C Hendrix; Elisabeth A Seftor; Richard E B Seftor; Jennifer Kasemeier-Kulesa; Paul M Kulesa; Lynne-Marie Postovit
Journal:  Nat Rev Cancer       Date:  2007-04       Impact factor: 60.716

Review 9.  The Pezcoller lecture: cancer cell cycles revisited.

Authors:  C J Sherr
Journal:  Cancer Res       Date:  2000-07-15       Impact factor: 12.701

10.  Human embryonic stem cell microenvironment suppresses the tumorigenic phenotype of aggressive cancer cells.

Authors:  Lynne-Marie Postovit; Naira V Margaryan; Elisabeth A Seftor; Dawn A Kirschmann; Alina Lipavsky; William W Wheaton; Daniel E Abbott; Richard E B Seftor; Mary J C Hendrix
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

View more
  16 in total

1.  Environmental chemical exposures and human epigenetics.

Authors:  Lifang Hou; Xiao Zhang; Dong Wang; Andrea Baccarelli
Journal:  Int J Epidemiol       Date:  2011-12-13       Impact factor: 7.196

Review 2.  Role of epigenetic aberrations in the development and progression of human hepatocellular carcinoma.

Authors:  Igor P Pogribny; Ivan Rusyn
Journal:  Cancer Lett       Date:  2012-02-02       Impact factor: 8.679

3.  The association between non-Hodgkin lymphoma and methylation of p73.

Authors:  Jing-Hong Pei; Sai-Qun Luo; Yan Zhong; Jiang-Hua Chen; Hua-Wu Xiao; Wei-Xin Hu
Journal:  Tumour Biol       Date:  2011-08-03

4.  High expression of H3K27me3 in human hepatocellular carcinomas correlates closely with vascular invasion and predicts worse prognosis in patients.

Authors:  Mu-Yan Cai; Jing-Hui Hou; Hui-Lan Rao; Rong-Zhen Luo; Mei Li; Xiao-Qing Pei; Marie C Lin; Xin-Yuan Guan; Hsiang-Fu Kung; Yi-Xin Zeng; Dan Xie
Journal:  Mol Med       Date:  2010-09-10       Impact factor: 6.354

Review 5.  Altered primary chromatin structures and their implications in cancer development.

Authors:  Angelo Ferraro
Journal:  Cell Oncol (Dordr)       Date:  2016-03-23       Impact factor: 6.730

Review 6.  Clinical significance of cell cycle inhibitors in hepatocellular carcinoma.

Authors:  Yasunobu Matsuda; Toshifumi Wakai; Masayuki Kubota; Masaaki Takamura; Satoshi Yamagiwa; Yutaka Aoyagi; Mami Osawa; Shun Fujimaki; Ayumi Sanpei; Takuya Genda; Takafumi Ichida
Journal:  Med Mol Morphol       Date:  2013-05-03       Impact factor: 2.309

7.  RNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cells.

Authors:  Guang-Ming Li; Yu-Gang Wang; Qin Pan; Jun Wang; Jian-Gao Fan; Chao Sun
Journal:  Int J Clin Exp Pathol       Date:  2014-02-15

8.  Nucleosomes correlate with in vivo progression pattern of de novo methylation of p16 CpG islands in human gastric carcinogenesis.

Authors:  Zhe-Ming Lu; Jing Zhou; Xiuhong Wang; Zhenpo Guan; Hua Bai; Zhao-Jun Liu; Na Su; Kaifeng Pan; Jiafu Ji; Dajun Deng
Journal:  PLoS One       Date:  2012-04-25       Impact factor: 3.240

9.  Breast cancer cells induce stromal fibroblasts to secrete ADAMTS1 for cancer invasion through an epigenetic change.

Authors:  Shiaw-Wei Tyan; Chih-Hung Hsu; Kai-Lin Peng; Chun-Chin Chen; Wen-Hung Kuo; Eva Y-H P Lee; Jin-Yuh Shew; King-Jen Chang; Li-Jung Juan; Wen-Hwa Lee
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240

10.  Promoter and histone methylation and p16(INK4A) gene expression in colon cancer.

Authors:  Ebru Esin Yoruker; Ufuk Mert; Dursun Bugra; Sumer Yamaner; Nejat Dalay
Journal:  Exp Ther Med       Date:  2012-08-24       Impact factor: 2.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.